Cross-Site Scripting vulnerability in the Repasat application. (CVE-2026-59673)
A Cross-Site Scripting (XSS) vulnerability exists in the Repasat application affecting the 'nomTipoCli' parameter at the endpoint '/es/clientypes/update/109441'. Exploitation could allow an attacker to trick users into executing arbitrary code in their browsers. No patch or remediation information is currently available.
AI Analysis
Technical Summary
CVE-2026-59673 describes a Cross-Site Scripting vulnerability in the Repasat application. The vulnerability affects the 'nomTipoCli' parameter on the '/es/clientypes/update/109441' endpoint. Successful exploitation could enable an attacker to execute arbitrary code in the context of a victim's browser by tricking the user. The vulnerability is classified under CWE-79. There is no vendor advisory or patch information provided, and no known exploits in the wild have been reported.
Potential Impact
If exploited, this vulnerability could allow an attacker to execute arbitrary scripts in the victim's browser, potentially leading to session hijacking, defacement, or other malicious actions within the user's browser context. However, no active exploitation has been reported.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until a fix is available, consider applying input validation or output encoding on the affected parameter as a temporary mitigation.
Cross-Site Scripting vulnerability in the Repasat application. (CVE-2026-59673)
Description
A Cross-Site Scripting (XSS) vulnerability exists in the Repasat application affecting the 'nomTipoCli' parameter at the endpoint '/es/clientypes/update/109441'. Exploitation could allow an attacker to trick users into executing arbitrary code in their browsers. No patch or remediation information is currently available.
CVSS v4.0
Weaknesses
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
CVE-2026-59673 describes a Cross-Site Scripting vulnerability in the Repasat application. The vulnerability affects the 'nomTipoCli' parameter on the '/es/clientypes/update/109441' endpoint. Successful exploitation could enable an attacker to execute arbitrary code in the context of a victim's browser by tricking the user. The vulnerability is classified under CWE-79. There is no vendor advisory or patch information provided, and no known exploits in the wild have been reported.
Potential Impact
If exploited, this vulnerability could allow an attacker to execute arbitrary scripts in the victim's browser, potentially leading to session hijacking, defacement, or other malicious actions within the user's browser context. However, no active exploitation has been reported.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until a fix is available, consider applying input validation or output encoding on the affected parameter as a temporary mitigation.
Technical Details
- Gcve Source
- db.gcve.eu
- Osv Id
- GHSA-p2x2-cvhw-27mp
- Osv Schema Version
- 1.4.0
- Aliases
- ["CVE-2026-59673"]
- Database Specific Severity
- MODERATE
- Cvss Version
- 4.0
- State
- PUBLISHED
Threat ID: 6abfee9ca43b0b3b89e5519b
Added to database: 10/02/2026, 17:49:16 UTC
Last enriched: 10/02/2026, 18:02:52 UTC
Last updated: 10/03/2026, 02:46:05 UTC
Views: 2
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.